Health Idea Now
Tuesday, 29 October 2019
Morphosys ends development of dermatitis treatment, shares fall
A development program for an atopic dermatitis treatment has failed, German biotech Morphosys said, sending its shares down 9% in early Frankfurt trade on Tuesday.
from Reuters: Health News https://ift.tt/2NpcwaY
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment